ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,249, issued on May 13, was assigned to Visterra Inc. (Waltham, Mass.).
"Interleukin-2 agents and uses thereof" was invented by Scott Moore Carlson (Boston), Gregory Babcock (Marlborough, Mass.), Zachary Shriver (Winchester, Mass.) and Boopathy Ramakrishnan (Braintree, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "IL-2 agents that comprise IL-2 variants are disclosed as well as methods, compositions, and uses thereof. The IL-2 agents described herein can be used to treat and/or prevent various disorders and conditions."
The patent was filed on March 25, 2024, under Application No. 18/616,055.
*For further information, including images, chart...